Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Cirrhosis

  Free Subscription


Articles published in Clin Res Hepatol Gastroenterol

Retrieve available abstracts of 42 articles:
HTML format
Text format



Single Articles


    March 2018
  1. BIHARI C, Patil A, Sarin SK
    Adequate platelet counts in cirrhosis for laboratory-based optimum platelet functions.
    Clin Res Hepatol Gastroenterol. 2018 Mar 31. pii: S2210-7401(18)30044.
    PubMed     Text format    


  2. SUH SW, Choi YS, Hong SA, Kang H, et al
    Preoperative erythropoietin treatment improves survival following major hepatic resection in a cirrhotic rat model.
    Clin Res Hepatol Gastroenterol. 2018 Mar 23. pii: S2210-7401(17)30268.
    PubMed     Text format     Abstract available


  3. HUNG TH, Lee HF, Tseng CW, Tsai CC, et al
    Effect of proton pump inhibitors in hospitalization on mortality of patients with hepatic encephalopathy and cirrhosis but no active gastrointestinal bleeding.
    Clin Res Hepatol Gastroenterol. 2018 Mar 15. pii: S2210-7401(17)30267.
    PubMed     Text format     Abstract available


  4. MALLET M, Weiss N, Thabut D, Rudler M, et al
    Why and when to measure ammonemia in cirrhosis?
    Clin Res Hepatol Gastroenterol. 2018 Mar 15. pii: S2210-7401(18)30031.
    PubMed     Text format     Abstract available


    December 2017
  5. SANG W, Lv B, Li K, Lu Y, et al
    Therapeutic efficacy and safety of umbilical cord mesenchymal stem cell transplantation for liver cirrhosis in Chinese population: A meta-analysis.
    Clin Res Hepatol Gastroenterol. 2017 Dec 6. pii: S2210-7401(17)30259.
    PubMed     Text format     Abstract available


    November 2017
  6. BRUSTIA R, Savier E, Scatton O
    Physical exercise in cirrhotic patients: Towards prehabilitation on waiting list for liver transplantation. A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2017 Nov 18. pii: S2210-7401(17)30214.
    PubMed     Text format     Abstract available


    October 2017
  7. ZHANG CH, Zheng L, Gui L, Lin JY, et al
    Soluble epoxide hydrolase inhibition with t-TUCB alleviates liver fibrosis and portal pressure in carbon tetrachloride-induced cirrhosis in rats.
    Clin Res Hepatol Gastroenterol. 2017 Oct 11. pii: S2210-7401(17)30187.
    PubMed     Text format     Abstract available


  8. LEMOINNE S, Marteau P
    Gut microbial profile in primary biliary cholangitis: Towards bioindicators.
    Clin Res Hepatol Gastroenterol. 2017;41:507-508.
    PubMed     Text format    


    September 2017
  9. MURATORI P, Muratori L
    Autoantibodies in antimithocondrial antibodies negative primary biliary cholangitis.
    Clin Res Hepatol Gastroenterol. 2017;41:e47.
    PubMed     Text format    


    August 2017
  10. MA X, Sun D, Li C, Ying J, et al
    Statin use and virus-related cirrhosis: A systemic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2017 Aug 30. pii: S2210-7401(17)30180.
    PubMed     Text format     Abstract available


    April 2017
  11. SAXENA P, Bihari C, Mirza R, Bhadoria AS, et al
    Exogenous growth factor based regenerative therapy in alcoholic cirrhosis patients renders limited effect on hemostatic elements.
    Clin Res Hepatol Gastroenterol. 2017 Apr 12. pii: S2210-7401(17)30080.
    PubMed     Text format    


    March 2017
  12. JAMSHIDZADEH A, Heidari R, Latifpour Z, Ommati MM, et al
    Carnosine ameliorates liver fibrosis and hyperammonemia in cirrhotic rats.
    Clin Res Hepatol Gastroenterol. 2017 Mar 7. pii: S2210-7401(17)30009.
    PubMed     Text format     Abstract available


    February 2017
  13. LI K, Liu H, Guo T
    Th17/Treg imbalance is an indicator of liver cirrhosis process and a risk factor for HCC occurrence in HBV patients.
    Clin Res Hepatol Gastroenterol. 2017 Feb 3. pii: S2210-7401(17)30003.
    PubMed     Text format     Abstract available


  14. GRANT CR, Liberal R
    Liver immunology: How to reconcile tolerance with autoimmunity.
    Clin Res Hepatol Gastroenterol. 2017;41:6-16.
    PubMed     Text format     Abstract available


  15. WATSON A, Bul V, Staudacher J, Carroll R, et al
    The predictors of mortality and secular changes in management strategies in emphysematous gastritis.
    Clin Res Hepatol Gastroenterol. 2017;41:e1-e7.
    PubMed     Text format     Abstract available


    December 2016
  16. ZHENG L, Qin J, Sun L, Gui L, et al
    Intrahepatic upregulation of MRTF-A signaling contributes to increased hepatic vascular resistance in cirrhotic rats with portal hypertension.
    Clin Res Hepatol Gastroenterol. 2016 Dec 30. pii: S2210-7401(16)30203.
    PubMed     Text format     Abstract available


    August 2016
  17. FONTAINE H, Maynard M, Bouix C, Carrieri MP, et al
    Efficacy and safety of boceprevir-based triple therapy in HCV cirrhotic patients awaiting liver transplantation (ANRS HC29 BOCEPRETRANSPLANT).
    Clin Res Hepatol Gastroenterol. 2016 Aug 20. pii: S2210-7401(16)30098.
    PubMed     Text format     Abstract available


    July 2016
  18. TAS A, Olmez S, Yalcin MS
    A rare cause of elevated alpha fetoprotein in patient with cirrhosis.
    Clin Res Hepatol Gastroenterol. 2016 Jul 5. pii: S2210-7401(16)30084.
    PubMed     Text format    


    June 2016
  19. JARUVONGVANICH V, Sanguankeo A, Klomjit N, Upala S, et al
    Effects of caffeine consumption in patients with chronic hepatitis C: A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2016 Jun 24. pii: S2210-7401(16)30089.
    PubMed     Text format     Abstract available


    May 2016
  20. WOSIEWICZ P, Zorniak M, Hartleb M, Baranski K, et al
    Portal vein thrombosis in cirrhosis is not associated with intestinal barrier disruption or increased platelet aggregability.
    Clin Res Hepatol Gastroenterol. 2016 May 5. pii: S2210-7401(16)30048.
    PubMed     Text format     Abstract available


    April 2016
  21. LIU L, Zhang C, Hu Y, Zhou L, et al
    Changes in gut toll-like receptor-4 and nod-like receptor family pyrin domain containing-3 innate pathways in liver cirrhosis rats with bacterial translocation.
    Clin Res Hepatol Gastroenterol. 2016 Apr 6. pii: S2210-7401(16)30038.
    PubMed     Text format     Abstract available


  22. INGILIZ P, Mayr C, Obermeier M, Herbst H, et al
    Persisting hepatitis E virus infection leading to liver cirrhosis despite recovery of the immune system in an HIV-infected patient.
    Clin Res Hepatol Gastroenterol. 2016 Apr 4. pii: S2210-7401(16)30033.
    PubMed     Text format     Abstract available


    January 2016
  23. ZHU Q, Yuan B, Qiao GL, Yan JJ, et al
    Prognostic factors for survival after hepatic resection of early hepatocellular carcinoma in HBV-related cirrhotic patients.
    Clin Res Hepatol Gastroenterol. 2016 Jan 25. pii: S2210-7401(15)00298.
    PubMed     Text format     Abstract available


    November 2015
  24. RASZEJA-WYSZOMIRSKA J, Wunsch E, Krawczyk M, Rigopoulou EI, et al
    Assessment of health related quality of life in polish patients with primary biliary cirrhosis.
    Clin Res Hepatol Gastroenterol. 2015 Nov 24. pii: S2210-7401(15)00260.
    PubMed     Text format     Abstract available


  25. WANG J, Liu Y, Xie L, Li S, et al
    Association of IL-17A and IL-17F gene polymorphisms with chronic hepatitis B and hepatitis B virus-related liver cirrhosis in a Chinese population: A case-control study.
    Clin Res Hepatol Gastroenterol. 2015 Nov 3. pii: S2210-7401(15)00258.
    PubMed     Text format     Abstract available


  26. ABERGEL A, Rotily M, Branchoux S, Akremi R, et al
    Chronic hepatitis C: Burden of disease and cost associated with hospitalisations in France in 2012 (The HEPC-LONE study).
    Clin Res Hepatol Gastroenterol. 2015 Nov 3. pii: S2210-7401(15)00246.
    PubMed     Text format     Abstract available


    October 2015
  27. HASTIER A, Patouraux S, Canivet CM, Lebeaupin C, et al
    Nonalcoholic steatohepatitis cirrhosis and type 1 refractory celiac disease: More than a fortuitous association?
    Clin Res Hepatol Gastroenterol. 2015 Oct 29. pii: S2210-7401(15)00249.
    PubMed     Text format    


  28. GAO PJ, Gao J, Li Z, Hu ZP, et al
    Liver transplantation in adults with portal vein thrombosis: Data from the China Liver Transplant Registry.
    Clin Res Hepatol Gastroenterol. 2015 Oct 20. pii: S2210-7401(15)00121.
    PubMed     Text format     Abstract available


  29. BEUERS U, Gershwin ME, Gish RG, Invernizzi P, et al
    Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.
    Clin Res Hepatol Gastroenterol. 2015;39:e57-9.
    PubMed     Text format    


    July 2015
  30. BERENGUER M
    Management of HCV in the liver transplant setting.
    Clin Res Hepatol Gastroenterol. 2015 Jul 20. pii: S2210-7401(15)00114.
    PubMed     Text format     Abstract available


  31. MACHADO MV, Cortez-Pinto H
    Proangiogenic factors in the development of HCC in alcoholic cirrhosis.
    Clin Res Hepatol Gastroenterol. 2015 Jul 17. pii: S2210-7401(15)00131.
    PubMed     Text format     Abstract available


  32. ZHU W, Chang-Li L, Mao-Yao W, Li Y, et al
    Persistent abnormal liver function tests may predict development of cirrhosis in chronic hepatic graft-versus-host disease.
    Clin Res Hepatol Gastroenterol. 2015 Jul 13. pii: S2210-7401(15)00143.
    PubMed     Text format    


    June 2015
  33. KAYADIBI H, Sertoglu E, Uyanik M
    Clinical situations that lead to misinterpretation of indirect biochemical indexes in liver diseases.
    Clin Res Hepatol Gastroenterol. 2015;39:e41-2.
    PubMed     Text format    


    May 2015
  34. QI X, Su C, Ren W, Yang M, et al
    Association between portal vein thrombosis and risk of bleeding in liver cirrhosis: A systematic review of the literature.
    Clin Res Hepatol Gastroenterol. 2015 May 5. pii: S2210-7401(15)00081.
    PubMed     Text format     Abstract available


    April 2015
  35. MA JQ, Ding J, Zhang L, Liu CM, et al
    Protective effects of ursolic acid in an experimental model of liver fibrosis through Nrf2/ARE pathway.
    Clin Res Hepatol Gastroenterol. 2015;39:188-97.
    PubMed     Text format     Abstract available


    January 2015
  36. MAO W, Hu Y, Lou Y, Dou J, et al
    Immature platelet fraction values predict recovery of platelet counts following liver transplantation.
    Clin Res Hepatol Gastroenterol. 2015 Jan 12. pii: S2210-7401(14)00294.
    PubMed     Text format     Abstract available


    November 2014
  37. TAM N, Zhang C, Lin J, Wu C, et al
    Simultaneous pancreas and kidney transplantation for liver transplant recipients with diabetes and uremia.
    Clin Res Hepatol Gastroenterol. 2014 Nov 4. pii: S2210-7401(14)00244.
    PubMed     Text format     Abstract available


    September 2014
  38. HIMOTO T, Tanaka N, Saito A, Muro Y, et al
    Diversity of humoral responses to the centromere proteins among HCV-related chronic liver disease, PBC and AIH patients.
    Clin Res Hepatol Gastroenterol. 2014 Sep 11. pii: S2210-7401(14)00184.
    PubMed     Text format     Abstract available


    August 2014
  39. POUJOL-ROBERT A, Boelle PY, Conti F, Durand F, et al
    Aspirin may reduce liver fibrosis progression: Evidence from a multicenter retrospective study of recurrent hepatitis C after liver transplantation.
    Clin Res Hepatol Gastroenterol. 2014 Aug 14. pii: S2210-7401(14)00166.
    PubMed     Text format     Abstract available


    June 2014
  40. KARAGOZ E, Tanoglu A
    Prognostic role of mean platelet volume in patients with chronic hepatitis C.
    Clin Res Hepatol Gastroenterol. 2014 Jun 19. pii: S2210-7401(14)00096.
    PubMed     Text format    


  41. PERAZZO H, Pais R, Munteanu M, Ngo Y, et al
    Variability in definitions of transaminase upper limit of the normal impacts the APRI performance as a biomarker of fibrosis in patients with chronic hepatitis C: "APRI c'est fini ?"
    Clin Res Hepatol Gastroenterol. 2014 Jun 9. pii: S2210-7401(14)00101.
    PubMed     Text format     Abstract available


    March 2014
  42. DUMORTIER J, Salame E, Roche B, Hurtova M, et al
    Severe fibrosis in patients with recurrent hepatitis C after liver transplantation: A French experience on 250 patients over 15 years (the Orfevre study).
    Clin Res Hepatol Gastroenterol. 2014 Mar 28. pii: S2210-7401(14)00051.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: